GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary. de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, et al. Kidney Int 2025;107:767-771.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, et al. GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary. Kidney Int 2025;107:767-771.
PMID: 40254354